| Optimizing the Implementation of Novel Diagnostic Tests for Prostate, Lung, and Colon Cancer |
Grant Langseth |
OncoCellMDx |
PLCO |
Dec 29, 2015 |
PLCO-185 |
| Accuracy of self-reported colonoscopy findings |
Paul Doria-Rose |
National Cancer Institute |
PLCO |
Dec 11, 2015 |
PLCO-180 |
| Validation of Endometrial Cancer Risk Prediction Model Developed Originally in the Nurses' Health Study |
Immaculata De Vivo |
Brigham and Women’s Hospital |
PLCO |
Dec 8, 2015 |
PLCO-182 |
| Digital Rectal Exam and Prostate Cancer Screening |
Joshua Halpern |
Weill Cornell Medical College |
PLCO |
Nov 30, 2015 |
PLCO-181 |
| Rates of PSA screening in PLCO |
Jonathan Shoag |
New York Presbyterian Hospital Weill Cornell |
PLCO |
Nov 20, 2015 |
PLCO-179 |
| DRE and LUTS |
Jonathan Shoag |
NA |
PLCO |
Nov 6, 2015 |
PLCO-177 |
| Flexible Sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Colorectal Cancer Survival by Trial Arm |
Maryam Doroudi |
National Cancer Institute |
PLCO |
Nov 4, 2015 |
PLCO-176 |
| Improving Lung Cancer Screening Rates and Smoking Documentation through Targeted Electronic Clinical Decision Support |
Travis Osterman |
Vanderbilt University Medical Center |
PLCO |
Nov 3, 2015 |
PLCO-175 |
| Optimal endoscopy screening and surveillance intervals for colorectal cancer |
Xin Zhou |
Harvard University |
PLCO |
Nov 2, 2015 |
PLCO-174 |
| Subset Analysis of Black Men Screened on the PLCO Prostate Cancer Screening Trial |
Curtiland Deville |
Johns Hopkins University |
PLCO |
Nov 2, 2015 |
PLCO-172 |
| Examining the association between the dietary inflammatory index (DII) and pancreatic cancer risk and potential mediation by type-2 Diabetes Mellitus (DM) |
Susan Steck |
University of South Carolina |
PLCO |
Oct 23, 2015 |
PLCO-171 |
| The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-155 |
| The importance of publishing on clinical trial operations |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-156 |
| The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-157 |
| Building Successful Relationships in the PLCO Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-158 |
| Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-159 |
| Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-160 |
| Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-161 |
| Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-162 |
| The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-163 |
